(Total Views: 93)
Posted On: 03/18/2025 9:00:25 AM
Post# of 83
MindMed Appoints Matt Wiley as Chief Commercial Officer
https://www.businesswire.com/news/home/202503...al-Officer
“Matt’s deep experience in launching multiple neuroscience and psychiatric therapeutics will be invaluable as we prepare for our first potential FDA approval of MM120 ODT,” said Rob Barrow, Chief Executive Officer of MindMed.
https://www.businesswire.com/news/home/202503...al-Officer
“Matt’s deep experience in launching multiple neuroscience and psychiatric therapeutics will be invaluable as we prepare for our first potential FDA approval of MM120 ODT,” said Rob Barrow, Chief Executive Officer of MindMed.
(0)
(0)
